Korro Bio, Inc.KRRO

$12.99+1.94 (+17.56%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$151M

Micro-cap

-64%

2019 — today

10-Year Price

-98%

2019 — today

52-Week Range

$5.28$51.36

Current $12.99· 17%

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

Valuation in context

P/E ratio

-1.1

N/A

Not meaningful — company is unprofitable

P/B ratio

1.3

Below average

Below the 10-year average

FCF Yield

-46.9%

Below average

Below the 10-year average

Free · No credit card needed

Get alerted when KRRO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.